- Patent Title: Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation
-
Application No.: US15128496Application Date: 2015-04-08
-
Publication No.: US10307389B2Publication Date: 2019-06-04
- Inventor: Eskil Elmer , Magnus Joakim Hansson , Karl Henrik Johannes Ehinger , Sarah Piel , Steven Moss
- Applicant: NEUROVIVE PHARMACEUTICAL AB
- Applicant Address: SE Lund
- Assignee: NEUROVIVE PHARMACEUTICAL AB
- Current Assignee: NEUROVIVE PHARMACEUTICAL AB
- Current Assignee Address: SE Lund
- Agency: Dann, Dorfman, Herrell & Skillman
- Agent Robert C. Netter, Jr.
- Priority: DK201470185 20140408; DK201470187 20140408; DK201470190 20140408
- International Application: PCT/EP2015/057615 WO 20150408
- International Announcement: WO2015/155238 WO 20151015
- Main IPC: A61K31/225
- IPC: A61K31/225 ; A61K45/06 ; A61K31/155
Abstract:
The present invention relates to a succinate prodrug for use in the treatment or prevention of lactic acidosis.
Public/Granted literature
Information query
